National Health Investors, Inc. (NHI)

NYSE Real Estate Health Care REITs S&P SmallCap 600
$71.24
-0.34 (-0.47%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+6.3%
1M+10.3%
3M-3.9%
6M-5.3%
YTD-6.7%
1Y-6.5%
3Y+41.8%
5Y+32.5%

Key statistics

Full financials →
Market cap$3.5B
P/E (TTM)20.6
EPS (TTM, diluted)$3.46
P/S26.16
P/B2.23
EV / EBITDA—
Revenue (TTM)$134.00M
Revenue growth+139.1%
Net margin124.7%
ROE10.6%
Debt / equity0.72
FCF yield-1.6%
Dividend yield5.19%
Payout ratio107%
Beta (1Y)-0.28
Volatility (1Y)24.2%
52-week range$63.51 – $91.38
Avg volume (50D)337.03K

Revenue & net income — last 8 quarters

Statements →

Chart pattern: Double Top (weekly)

Forming
NHI Double Top chart

Trigger $63.51 (-10.9% away). Details →

Aug 27, 4:08 PM ET

National Health Investors enters change-in-control severance agreement with Christian Maingot

Neutral leadership Written later 5.02

National Health Investors entered a Change in Control Severance Agreement with executive Christian Maingot, effective August 27, 2026. The agreement sets severance terms that apply if his employment ends without cause or for good reason within two years after a change in control, or without cause within 30 days before one.

  • Agreement with Christian Maingot dated and effective August 27, 2026, filed as Exhibit 10.1
  • Severance includes a lump sum of 2.0 times the average of base salary and bonus over the most recent two calendar years
  • Also includes a lump sum equal to the greater of target bonus or earned bonus, pro-rated, plus 18 months of COBRA coverage and accelerated time-based equity vesting
  • Includes 12-month post-employment non-compete and non-solicitation restrictions if severance is paid
Read the filing on SEC.gov ↗
Aug 10, 4:10 PM ET

NHI Q2 EPS rises 45.6% to $1.15; normalized FFO per share dips 2.5% to $1.19

Mixed earnings Written later 2.02

National Health Investors reported second quarter 2026 results, with diluted earnings per share of $1.15 versus $0.79 a year earlier, helped by $22.0 million of property disposition gains. Normalized FFO per diluted share fell 2.5% to $1.19 for the quarter, though the company also raised its quarterly dividend to $0.94 from $0.92 and issued 2026 full-year NAREIT FFO guidance of $4.74 to $4.79 per diluted share.

  • Diluted EPS of $1.15 for Q2 2026 vs. $0.79 in Q2 2025; six-month diluted EPS of $1.97 vs. $1.53
  • Normalized FFO per diluted share of $1.19 for Q2 2026 vs. $1.22 in Q2 2025; six-month figure rose 2.1% to $2.42
  • Quarterly dividend increased to $0.94 per share from $0.92, payable November 6, 2026
  • NHC portfolio sale closed July 1, 2026 for $560.0 million in cash consideration
Read the filing on SEC.gov ↗
Jul 27, 9:02 AM ET

NHI appoints Christian Maingot as chief operations officer effective July 27, 2026

Neutral leadership Written later 5.02

National Health Investors named Christian Maingot as its first Chief Operations Officer, effective July 27, 2026. He most recently served as CEO of Longview Senior Housing, a Blackstone portfolio company, from May 2022 to April 2026, and has more than 20 years of senior housing experience. The filing sets out his initial compensation, which matters to shareholders because it shows the cost of the new executive role.

  • Board appointed Maingot on July 22, 2026; role effective July 27, 2026
  • Initial annual base salary of $415,000
  • Maximum 2026 performance-based cash bonus of $360,937 (prorated), plus a 2026 equity award with a target value of $375,833 (prorated), split equally between time-based restricted stock and performance-based restricted stock units
  • Previously spent more than a decade at Brookdale Senior Living, most recently as Senior Vice President of Corporate Development and Strategic Initiatives
Read the filing on SEC.gov ↗
Jul 1, 4:32 PM ET

National Health Investors closes $560 million sale of 35 facilities to NHC unit

Neutral m&a Written later 1.022.01

National Health Investors completed the sale of 35 facilities, including 32 skilled nursing facilities and three independent living facilities, to subsidiaries of National HealthCare Corporation (NHC) for a total purchase price of $560 million, effective July 1, 2026. The Master Lease was terminated for all facilities except four Florida skilled nursing facilities, which were assigned to an NHC subsidiary. NHC is a shareholder of the company, and a special committee of independent directors unanimously approved the transaction, but the filing does not state the effect on future rental income or earnings.

  • Transaction closed July 1, 2026 at a total purchase price of $560 million for the property
  • Sold 35 facilities: 32 skilled nursing facilities and three independent living facilities
  • Master Lease terminated for all facilities except four Florida skilled nursing facilities, assigned to an NHC subsidiary
  • NHC owned 1,630,642 shares of the company's common stock as of December 31, 2025; a special committee of independent directors unanimously approved the deal
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Famous investors who own NHI

All investors →
InvestorValue% of portfolioLast quarter
Renaissance Technologies $3.97M0.01% Added

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All NHI congressional trades →
TradedMemberTypeAmount
Jul 10, 2026Gilbert Cisneros CA-31Buy$1,001 – $15,000
Jan 15, 2026Gilbert Cisneros CA-31Buy$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from National Health Investors, Inc.'s SEC XBRL filings. Not investment advice.